Enobia Pharma
Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments. Our lead product in development, ENB-0040 (human recombinant tissue non-specific alkaline phosphatase), is a subcutaneous bone-targeted enzyme replacement therapy for the rare disease hyposphostasia.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
8
11 to 50 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Enobia Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
Showing 1 of 5 verified contacts
Top roles at Enobia Pharma
5 distinct titles indexed · top 5 shown.
- 1chefe
- 1cmo
- 1consultant
- 1senior clinical study manager
- 1vice-président finance et administration
Sign up to unlock all 5 contacts at Enobia Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Enobia Pharma
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.